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Abstract
Most RNA molecules are co- or post-transcriptionally modified to alter their chemical and functional properties to assist in
their ultimate biological function. Among these modifications, the addition of 59 cap structure has been found to regulate
turnover and localization. Here we report a study of the cap structure of human short (,200 nt) RNAs (sRNAs), using
sequencing of cDNA libraries prepared by enzymatic pretreatment of the sRNAs with cap sensitive-specificity, thin layer
chromatographic (TLC) analyses of isolated cap structures and mass spectrometric analyses for validation of TLC analyses.
Processed versions of snoRNAs and tRNAs sequences of less than 50 nt were observed in capped sRNA libraries, indicating
additional processing and recapping of these annotated sRNAs biotypes. We report for the first time 2,7 dimethylguanosine
in human sRNAs cap structures and surprisingly we find multiple type 0 cap structures (mGpppC, 7mGpppG, GpppG,
GpppA, and 7mGpppA) in RNA length fractions shorter than 50 nt. Finally, we find the presence of additional
uncharacterized cap structures that wait determination by the creation of needed reference compounds to be used in TLC
analyses. These studies suggest the existence of novel biochemical pathways leading to the processing of primary and
sRNAs and the modifications of their RNA 59 ends with a spectrum of chemical modifications.
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Introduction
The conventional and recently identified novel functional roles
of RNA underscore their continuing emerging importance. Many
of these roles are dependent on co- or post-transcriptional
chemical modifications. Among these modifications is the addition
of 7-methylguanosine cap (7 mG) to the 59 termini of elongating
mRNA transcripts. This modification has been observed to play
important roles in the extra-nuclear transport, translation and
overall RNA stability [1]. Beyond helping to regulate long (.
200 nt) mRNAs, several biotypes of short (s) RNAs have been
observed to possess 59 cap structures [2]. sRNAs have been
observed to possess a trimethylated version (2,2,7 mG) of the
7 mG cap structure. This modification has been reported as part
of short nuclear RNAs (snRNAs) and nucleolar RNAs (snoRNAs).
These short capped RNAs have been intensively studied for their
role in gene expression, splicing regulation and long RNA editing
[3]. Other modifications of 59 caps have been found, in particular
a c-mono-methyl cap structure for the U6 snRNA [4,5], and
2,7 mG in virus RNAs [6,7]. In contrast, other well-characterized
sRNA biotypes such as microRNAs (miRNAs), Piwi-interacting
RNAs (piRNAs) and most snoRNAs, lack a 59 cap structure, as
demonstrated by the ability of cloning experiments to selectively
capture these monophosphate 59 ends without a cap [8].
While the use of a combination of 59 cap dependent cloning
(using cap analysis of gene expression, CAGE and RNA
Annotation and Mapping of Promoters for the Analysis of Gene
Expression, RAMPAGE) and RNA sequencing (RNAseq) has
allowed for the discovery and mapping of novel long and short
capped RNAs, the landscapes of modifications observed at the
59ends of these RNAs are largely unexplored. Results from
FANTOM and ENCODE projects both indicate that the total
number of capped long transcripts is much greater than the
protein coding RNAs in mouse [9] and human samples [10,11].
The variety of the types of 59 end modifications for sRNAs is
particularly unexplored. A cause for this dearth of knowledge lies
primarily in the reasoning that sRNAs cannot be mapped as
accurately as long RNAs as well as that these sRNAs are random
short-lived degradation products of long RNAs and thus are
biologically unimportant.
These views have more recently come under reconsideration
with the identification of novel biotypes of biologically active
sRNAs. For example, sRNAs derived from processed snoRNAs
[12] and tRNAs [8,13] have been identified as being involved in
gene regulation and cell proliferation, respectively. Additionally,
promoter/termini-associated sRNAs (PASRs and TASRs, respec-
tively) have been identified which when present are able to have a
repressive effect on transcription [14,15]. Notably, characteriza-
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tion of PASRs indicates that these sRNAs appear to be capped
because these RNAs can be selectively immunoprecipated by
antibodies raised against 7 mG and 2,2,7 mG cap structures [16–
18]. Other capped sRNAs and a cytosolic capping protein
complexes have been identified during studies involving the
cleavage and recapping of long RNAs [14,19]. These observations
point to the possibility of not only additional capped sRNA
biotypes but also to additional kinds of chemical modifications
associated with the cap structures. Here, we have applied pre-
[4,20,21] and post-genomics methods to sRNAs extracted from
the THP-1 cell line to explore the range of chemical modifications
found associated with the 59cap structures.
Materials and Methods
Nomenclature
Methylated bases are abbreviated as follows. 1 mG: 1-
methylguanosine; 2 mG: N2- methylguanosine; 7 mG: 7-methyl-
guanosine; 2,2 mG: N2,N2-dimethylguanosine; 2,7 mG: N2,7-
dimethylguanosine; 2,2,7 mG: N2,N2,7-trimethylguanosine; Cm:
29-O-methylcytidine. Phosphorylated bases are indicated as
follows, in combination with methylations. Np: 59 nucleotide
monophosphate. Npp: 59 nucleotide diphosphate. Nppp: 59
nucleotide triphosphate. NpppN: 59-59 nucleotide triphosphate.
sRNA CAGE libraries
The starting material for all the libraries was sRNA isolated
from THP-1 cells using the mirVana kit (Ambion) according to
manufacturer’s instructions. In brief, the 39 ends of 3 mg of sRNA
were ligated to 59 pre-adenylated and 39 blocked adapters (59-
rApp/CTGTAGGCACCATCAAT/3ddC-39) using a truncated
T4 RNA ligase 2 enzyme (NEB). Ligated sRNAs were purified by
ethanol precipitation, and reverse transcribed using an oligonu-
cleotide complementary to the 39 adaptor and that had an
EcoP15I at its 59 end (59- AAGGTCTATCAGCAGAAAAATT-
GATGGTGCCTACAG-39). The later steps of libraries prepara-
tion were performed according the CAGE protocol [22]. The
cDNAs were amplified using 18 PCR cycles using a primers
targeting the 59 linker and 3-linker with additional sequence for
bridge PCR on Illumina sequencers.
Immunoprecipitated sRNAs
Three batches of 26107 THP-1 cells were lysed using the
mirVana Kit lysis buffer (600 ml, Life Technologies). The cell
lysate was diluted in 106IP buffer (25 mM Tris-HCl pH 7.5,
150 mM KCl, 1 mM DTT, 16protease inhibitor, 0.1% NP40).
The mixture was centrifuged 14,000 rpm for 15 min at 4uC. The
supernatants were divided into three tubes for immunoprecipita-
tion with the monoclonal K121 antibody, and three tubes for the
IP negative controls. 10 mg of antibody or 1 ml of RNase-DNase
free water (Gibco) for the negative controls were mixed with 1 ml
of cell lysate in the presence of 40 U of RNaseOUT and rotated
overnight at 4uC. 100 ml of washed Dynabeads protein G (cat.
#100.03 Invitrogen) were added and the tubes were rotated at
4uC for an extra 5 h. G beads were washed 3610 min at 4uC with
200 ml IP buffer, re-suspended in 200 ml IP buffer and then
supplemented with 50 mg Protease K. RNA was separated from
the beads by incubating at 40uC for 30 min, extracted with
phenol/chloroform and ethanol precipitated.
Capped sRNA libraries
We prepared libraries from the immunoprecipitated RNA and
from 1.6 mg aliquots of THP-1 sRNA extracted by the mirVana
kit (Ambion). All RNAs except for one set of control libraries (to
capture sRNAs that have a 59 phosphate) were dephosphorylated
with shrimp alkaline phosphatase (SAP, USB) according to the
manufacturer’s recommendation, and then decapped with 1 U of
tobacco acid pyrophosphatase (TAP, Epicentre) in the presence of
20 U of RNaseOUT. The moderate amount of TAP was chosen
because of a residual RNAse activity of the enzyme (Figure S1 in
File S1). The decapped RNA was recovered by extraction with
phenol/chloroform and ethanol precipitated, and used to prepare
libraries based on 59 adapter ligation [23].
Sequencing and data analysis
Libraries were loaded in a HiSeq 2000 sequencer (Illumina) at a
10 pM final concentration, with single reads of 100 nt. All the data
has been deposited in the DNA DataBank of Japan’s Sequence
Read Archive (DDBJ SRA) under the accession number
DRA001138.
The reads contained sample indexes used by the HiSeq software
pipeline to de-multiplex the libraries. Tags were clipped from the
reads using the FASTX-Toolkit program (http://hannonlab.cshl.
edu/fastx_toolkit/), requiring a match of at least 8 bases. Thus, we
could infer the length of the RNAs shorter than 93 nt. 100-nt tags
represent longer RNAs. Unlike in other libraries, the sRNA CAGE
tags had a fixed size peaking at 27 nt because of the enzymatic
cleavage by the EcoP15I enzyme. We removed all the tags that
had exact matches with the reference human ribosomal DNA unit
(GenBank: U13369) using the rRNAdust program (available upon
request). The reads were then aligned with BWA [24].
The TSS and TTS plots were calculated by counting the
number of reads aligned to windows of 100 nt centered on the
start and end positions from the ‘‘protein_coding’’ or ‘‘lncRNA’’
transcript models of GENCODE 17. Counts per category were
computed with BEDTools [25] and R (R Foundation for
Statistical Computing, 2008, ISBN 3-900051-07-0) with scripts
available upon request.
We annotated the aligned sRNAs using our in-house annotation
pipeline (source code available upon request). The annotations
were then resolved hierarchically with the following categories in
increasing order of priority: unknown, intron, exon, miRNA,
snRNA, snoRNA, tRNA.
RNA fractionation by electrophoresis for thin layer
chromatography (TLC)
sRNAs were isolated from THP-1 cells using the mirVana kit
(Ambion) according to the manufacturer’s instructions, precipi-
tated with isopropanol and re-suspended in 10 ml RNase-DNase
free water (Gibco), mixed with equal volume of gel loading dye
(Ambion), heat denatured for 5 min and then cooled immediately
on ice before separation on a 15% (w/v) denaturing acrylamide gel
(16TBE, 7 M urea, 15% acrylamide (29:1 acryl:bis-acryl) in
16TBE running buffer. The gel was stained with SYBR Gold
(Invitrogen, Carlsbad, CA) for 5 min, and size fractions were
collected by cutting the gel into three slices (,50 nt, 50–100 nt,
100–200 nt) according to a RNA molecular weight marker (RNA
lowII, DynaMarker) (Figure S2 in File S1). The gel slices were
transferred to a 2 ml clean tube RNase- and DNase-free and
smashed by passing through a membrane-less filter (illustra
MicroSpin columns, GE Healthcare). RNA was eluted in 1 ml
of TEN buffer (Tris-HCl (pH 8.0) 8 mM, EDTA 0.1 M, NaCl
240 mM in RNase-free water), rocking overnight at 4uC. The
tubes were then centrifuged 5 min at 10,0006g speed, the aqueous
phase was recovered and the RNA was ethanol precipitated and
re-suspended in RNase, DNase free water.
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Preparing the 59 cap standards
For the preparation of cap standards, a T7 RNA polymerase
promoter was incorporated into a PCR product containing 326 bp
of the bacteriophage lambda genome (GenBank: J02459.1,
Lambda Phage DNA: Wako cat. #91080-14-7) with the forward
primer TAATACGACTCACTATAGGGcgtttccgttcttcttcgtc and
the reverse primer cgcagcttttcgttctcaat. The gel extracted PCR
product was used as template for T7 RNA transcription (MEGA-
script T7, Ambion). The purified RNA fragment was capped using
vaccinia virus capping enzyme (Ambion) in the presence of
[a-32P]GTP. The 32P labeled 7 mG cap was purified to partially
remove unincorporated [a-32P]rGTP by three consecutive Probe-
Quant G-50 micro column (GE healthcare), using the remaining
unincorporated Gppp (further shortened to Gp in a later step) as
one of the standards. Methyltransferase reactions (10 ml) were
performed according to literature [26] using the trimethylguano-
sine synthase from Giardia lamblia (GlTgs2) to prepare 2,7 mG-
capped RNA, and human TGS-1 (huTgs1) to prepare 2,2,7 mG-
capped RNA. GITgs2 (GenBank accession number
XP_001704513) cloned into the Escherichia coli expression vector
pET200D (Invitrogen) plasmid was a generous gift from Dr
Barbosa at the University of California, Los Angeles. Induction of
expression and purification of the N-terminal His-tagged GlTgs2
was carried out as described [27]. Short isoform of TGS-1 (GST-
huTgs1-sf) plasmid (pGEX background) was a generous gift from
Dr Bordonne at Universite´ Toulouse III Paul Sabatier. Induction
of expression and purification of the GST-tagged huTgs1-sf were
carried out as described in [28]. Protein purity and concentration
were evaluated by SDS-PAGE and densitometry using BSA
standards. The labeled cap structures were released with TAP
(Epicentre), using the same digestion procedure as above.
Determination of the affinity of the K121 antibody to
methylguanosines
Standard capped RNAs were mixed in IP buffer (25 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 0.5 mM DTT, 16protease
inhibitor). The mixture was divided into four aliquots of 200 ml,
three for the immunoprecipitation, and the fourth for IP library
negative control. 30 mg (300 ml) of mouse monoclonal antibody
against 7 mG and 2,2,7 mG caps clone K121 (Calibochem cat.
#D00036157) [29] and 300 ml of RNase- DNase free water
(Gibco) for the negative control were mixed with standard capped
RNAs in the presence of 40 U of RNaseOUT and rotated over
night at 4uC. 100 ml of washed Dynabeads protein G (cat.
#100.03 Invitrogen) were added to each tube and the tubes were
rotated at 4uC for an extra 5 h. G beads were washed 3610 min
at 4uC with 200 ml IP buffer, re-suspended in 200 ml IP buffer and
then supplemented with 50 mg Protease K. The RNAs were
separated from the beads by incubating at 40uC for 30 min,
extracted with phenol/chloroform and ethanol precipitated. The
labeled cap structures were released with tobacco acid pyropho-
sphatase (TAP, Epicentre), using the manufacturer’s procedure.
The replicates were analysis on one or two dimension TLC system
as described below (Figures S3–S5 in File S1).
59 end labeling of fractionated RNA
Fractionated RNA was decapped 1 h at 37uC in a volume of
10 ml containing 50 mM sodium acetate pH 5.1, 1 mM EDTA, 20
U RNaseOUT (Invitrogen), and 1 U TAP (Epicenter)/150 pmol
RNA. The enzyme was heat-inactivated at 65uC for 10 min, and
the cleavage products were dephosphorylated by adding 1 mM
MgCl2 and 5 U of antarctic phosphatase (AP, NEB), incubating at
37uC for 30 min then heat inactivating at 65uC for 20 min. The 59
cap structures were radiolabelled with 4 U T4 polynucleotide
kinase (PNK, USB) and 2 mM final concentration of ATP, in
16PNK buffer in the presence of 50 pmol [c-32P]ATP (3000 Ci/
mmol) [30]. T4 PNK reaction was incubated at 37uC for 1 h and
then deactivated at 65uC for 10 min. 1 ml of apyrase (NEB) was
added to the reaction mixture to digest the un-incorporated
[c-32P]ATP.
Aliquots of individual RNA fraction’s reactions were analyzed
by 2D TLC analysis with 10610 cm plain cellulose TLC plates
(Merck) loaded with 0.5 mg of monophosphate ribonucleotide
(rAMP, rCMP, rGMP, UMP) and 300–800 c.p.m. of the 32P
labeled cap standards (Figure S6 in File S1). The first dimension
was developed with solvent A (isobutyric acid: ammonia: water)
(66:1:33) to separate on negative charge on the phosphate groups
and in the second dimension with solvent B (n-propanol:
ammonium sulfate: phosphate buffer) (100:60:2 V:W:V) to
separate on the polarity of nucleotide bases [26,31,32].
We performed the following controls to ensure for the specificity
of our chromatographies. First, we confirmed that RNAs prepared
by omitting the TAP and AP were not eluted from the loading spot
(Figure S7A in File S1), indicating that the sRNA preparations did
not contain small nucleotides prior digestion. Second, RNA
treated with RNAse I followed by T4 PNK treatment migrated
away from the loading spot without forming spots corresponding
to cap structure (Figure S7B in File S1). Third, no signal
corresponding to cap structures was observed when omitting the
TAP only (Figure S7C in File S1), confirming that liberation of the
caps by TAP treatment was strictly necessary to observe the spot
pattern.
We also controlled the activity of the T4 PNK on 59-hydroxyl
nucleosides, since this is the expected product of our enzymatic
treatments of the 59 caps. We used as substrates a mixture of the
four monophosphate ribonucleotide (rAMP, rCMP, rGMP, UMP)
for labeling reaction without or with prior dephosphorylation
(Figure S8 in File S1, panels AB and CD respectively) in the
presence of [c-32P]ATP or ATP:[c-32P]ATP, 1:1 (Figure S8 in File
S1, panels AC and BD respectively).
We assigned the spots according to Keith 1999 [33] for position
and [34] for chemical structure reference, and quantified the spots
with the ImageJ software for fractionated sRNA TLC (Figure S6
in File S1) and Multi-Gauge for immunoprecipitated standards
TLC. The intensity of the TLC spots was averaged across
replicates after subtracting background intensity and normalizing
to the total intensity of all the quantified spots at the same TLC
plate. The intensity of spotting origins were saturated in all
measurements therefore we were not able to normalize to origin
intensity.
RNA fractionation by HPLC for mass spectroscopy
analysis
sRNA was isolated from THP-1 cells using the mirVana kit
(Ambion) according to manufacturer’s instructions, and fractio-
nated using micro-reverse phase liquid chromatography with
modified condition from (DICKMAN1 and HORNBY2 2006).
We used a polystyrene-divinylbenzene PLRP-300 column
(3 mm62 mmID6100 mmL) at 60uC with a flow-rate of 50 mL/
min. sRNA was injected at 50 mg/100 ml at time. The RNA
fractions were collected at equivalent to 20–50 nt, 50–100 nt,
100–200 nt, and 200–300 nt according to the elution profile of a
sRNA ladder (Figure S9 in File S1). We made a gradient of eluent
A (100 mM triethylammonium acetate in water TEA-AA) and
eluent B (acetonitrile in buffer A, A/CH3CN=60/40). The
gradient lasted for 80 min and started with 20% B in A.
Concentration of eluent B was extended to 31% in 1 min,
59 Caps in Small RNAs
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followed by an extension to 41% eluent B over 19 min, followed
by extension to 70% in 1 min, and elution with 70% eluent B over
9 min. The column was then washed for 40 min with 20% of
eluent B. The fractionated RNA was later precipitated using
isopropanol and glycogen as a carrier.
Alignment of Tandem mass spectroscopy
We calibrated and tuned the tandem MS/MS system with the
following cap analogs: non-methylated cap analog GpppG
(Epicentre), monomethylated cap analog 7mGpppG (Epicentre),
dimethylated cap analog 39-Om,7mGmpppG (39-0-Me
m7G(59)ppp(59)G, NEB), and trimethylated cap analog
2,2,7mGpppG (Epicentre). The cap analogs were separated by
HPLC and introduced to the spectrometer by electrospray
ionization (ESI).
Enzymatic digestion for mass spectroscopy
RNA fractionated either with PAGE or 150 mg using micro
liquid chromatography was digested for three hours at 37uC using
RNase T2 (MOB-Funakoshi) and Nuclease P1 from Penicillium
citrinum (Wako) in 20 mM ammonium acetate buffer pH 5.3. The
units used for each enzyme were adjusted according to the
manufacturer’s recommendation in order to release the cap core
as a 59-59 dinucleotide triphosphate despite the possible methyla-
tion on the penultimate nucleotide. A C30 monolithic trap column
was used to retain and concentrate hydrophobic cap structures
from digested RNA samples.
Results
Detection of capped sRNA with CAP Trapper
To detect the presence of caps at the 59 end of sRNAs, we
prepared sequence libraries using three different but complemen-
tary procedures (Figure 1). All libraries were prepared in triplicate
using sRNA extracted from THP-1 cells. Firstly, we prepared
sRNA libraries following a novel protocol combining the CAP
trapper chemistry and tag cleavage [14,29] with sRNA library
procedures. In this approach, the reverse-transcription used as
template a linker ligated to the 39 end of sRNAs. We refer to these
libraries as sRNA CAGE. These libraries contained in average
35% of reads aligning to loci encoding snRNAs, supporting our
intention that this protocol efficiently captured capped RNAs. The
other 65% of the reads correspond to multiple annotation
categories, the most abundant of which were sections of annotated
exons (15%).
Detection of sRNAs that contain pyrophosphate bonds
A hallmark characteristic of cap structures is the 59-59
triphosphate bond between the methylated guanosine and the
next nucleotide. In a second set of libraries, we detected RNAs
with cap structures by the specific cleavage of these 59-59 bonds
using tobacco acid pyrophosphatase (TAP) [35]. This cleavage
generates a 59 phosphate that makes the now uncapped sRNAs
competent for ligation and inclusion in the sequencing libraries.
This done by use of shrimp alkaline phosphatase (SAP) as a step
prior to the use of TAP. All naturally occurring 59-monopho-
sphorylated molecules (e.g. miRNAs) that are in the total RNA
pool are rendered incapable for inclusion in capped RNA libraries.
We refer to these libraries derived from 59 capped RNAs as
capped sRNA libraries. A separate sequencing library is created
for RNAs already possessing a 59 phosphate in the starting RNA
pool, which we called sRNA library.
To determine the length of the capped and uncapped sRNAs,
we used sequencing read lengths of single end 101 nt. The sRNA
libraries showed the expected prominence of miRNAs between
20–24 nt, while the capped sRNA libraries exhibited a more
complex pattern, with 54 % of these sRNA (Figure 2) showing
lengths greater than 20–24 nts. We then examined in more detail
the contents of the libraries by aligning each mapped read to the
annotated human genome. We first divided the annotated sets of
mapped reads into five size ranges that corresponded to average
lengths of different biotypes of annotated sRNAs: 0–18 nts (tiny [ti]
RNAs), 19–29 nt (miRNAs), 30–50 nt (TASRs and PASRs), 51–
100 nt (tRNAs) and 100–200 nt (snRNA [36], C/D and H/ACA
snoRNAs [3]). The most abundant (46%) size range of sRNA
biotypes of the capped sRNAs was the 19–29 nt. We also counted
7.4% of the RNAs in the 0–18 nt size range, mostly aligned to
exons, which are consistent with them being the tiRNA biotype
[12]. 6–8% of the lengths had a size in the 30–50 nt. In that length
class, we observed an enrichment for sRNA mapping to tRNA.
SnoRNA annotations were prominent in the 50–100 nt range.
The relative enrichment of these length classes and biotypes were
not observed in the control libraries (sRNA libraries). Altogether,
these enrichments show the presence of a diverse collection of
sRNAs containing phosphate-phosphate links, a component of
RNA cap structures.
Immunoprecipitation of methylguanosine-capped RNAs
from cell extracts
Capped RNAs were highly enriched in our sequencing libraries
due to the detection of a diol group (sRNA CAGE) or a
phosphate-phosphate bond (capped sRNA). As an orthogonal
means of detection, we prepared a third set of libraries from RNAs
enriched for methylguanosine-capped RNAs by immunoprecipita-
tion with the K121 monoclonal antibody compared to no-
antibody controls. We refer to these libraries as IP K121 and IP
control respectively. We determined that the K121 antibody had
its highest affinity for trimethyl G (2,2,7 mG) caps compared to
dimethyl and monomethyl G (2,7 mG and 7 mG, respectively) cap
structures (Figure S5 in File S1). The sRNAs present in each of the
two libraries were dramatically different in size distribution as well
as the annotations they mapped to. This was particularly seen for
sRNAs whose lengths were between 12–30 nt (Figure 2A). As
expected, in the IP libraries, miRNAs were rarely seen, as was
previously reported [12]. Interestingly, fragments of annotated
snRNAs in the 30–50 nt range were enriched in the IP K121
libraries. This enrichment was stronger than in the capped sRNA
libraries (Figure 3). The second most enriched sRNAs observed in
the IP K121 libraries were short RNAs (0–18 nt) that mapped
within 100 nt of TSSs of annotated gene regions (Figure S10 in
File S1). Such short capped RNAs in the IP K121 library are
similar to those seen in the capped sRNA libraries and are
consistent in the length described for tiRNAs.
Thin layer chromatography chemically identifies 59 cap
modifications enriched in specific sRNA fractions
To further explore the chemical structure of sRNA cap
structures, we isolated sRNAs by electrophoresis into three length
fractions (1–50 nt, 50–100 nt and 100–200 nt) in triplicate
experiments. The cap structures were isolated by incubating each
of the size-fractionated sRNAs with TAP. The liberated 59 cap
structures were first dephosphorylated followed by kination with
c-32P ATP. The cleavage products were then analyzed using two-
dimensional TLC on cellulose plates, eluting the first dimension
with isobutyric acid: ammonia: water (66:1:33) to separate on
nucleic acid bases, and the second dimension with n-propanol:
ammonium sulfate: phosphate buffer (100/60/2) to separate on
59 Caps in Small RNAs
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Figure 1. Construction of sequence libraries enriched for capped sRNAs. Step-by-step graphical summary of the construction of the sRNA
libraries. The bottom line indicates the library name; in the manuscript, these names are emphasized in italics. The key methods are
immunoprecipitation for the IP K121 and IP control libraries, TAP (or mock) treatment for the Capped sRNA and sRNA libraries, and CAP Trapper for
the sRNA CAGE libraries.
doi:10.1371/journal.pone.0102895.g001
Figure 2. Comparison of libraries identifies enriched sRNA lengths and annotations. A–C: Size profile of the immunoprecipitated (A), TAP-
treated (B) and CAP trapped sRNA libraries and their controls. D: Annotations per length range, represented by stacked bar plots for each library
replicate. None means that no annotation was found, and other combines all annotations categories that were not listed individually.
doi:10.1371/journal.pone.0102895.g002
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the polarity of molecule. We assigned the spots as published in
Kieth et al. and Perry et al. [33,37] using radiolabeled cap
standards for Gp, 7 mGp, 2,7 mGp, and 2,2,7 mGp, and cold
nucleotide monophosphates as a guide (Figure 4). We detected
methylguanosine caps in each size sRNA fractions. The spot
corresponding to 2,7 mGp could not be unambiguously identified
in all samples, as its position varied among replicates and was often
split or inhomogeneous in control experiments (Figure S6 in File
S1). However, in such cases, we could at least make a preliminary
decision based identifying specific spots based on one or two of the
replicas.
In addition to these caps for which we have radiolabelled
standards, we also detected spots that correspond to the presence
of unlabeled Ap, Up, Cp, Cmp, 1 mGp, 2 mGp, and 2,2 mGp
standards. The different cap structures candidates were quantified
using intensity percentage after normalization by subtraction of
background (Figure 5). In the fraction shorter than 50 nt, the most
intense spots corresponded to Gp, 2,2,7 mGp, and 2,2 mGp.
Interestingly, in the 50–100 fraction, the most intense spot was
2,2 mGp, a modified nucleotide that is commonly found in
tRNAs, for which this fraction was enriched. In addition, despite
the fact that those annotated sRNAs biotypes possessing
2,2,7 mG-capped are larger than 100 nt, we also found relatively
high amounts of this modified nucleotide in the ,50 nt fraction.
Overall, the most represented modified nucleotides, in descending
order, are Gp (which is the precursor of the canonical cap
structures 7 mGp and 2,2,7 mGp), 2,2 mGp, 2,2,7 mGp,
Figure 3. Differential expression analysis of annotated sRNAs. Enrichment of annotated tag clusters in the IP K121 and Capped sRNA libraries
respectively to their controls. Horizontal and vertical axis: fold changes in logarithmic scale. Each dot represents one cluster, with a size proportional
to its average expression.
doi:10.1371/journal.pone.0102895.g003
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Figure 4. Thin layer chromatography reveals cap structures on sRNAs at all length ranges. A–F: 2D-TLC of radiolabelled cap structures.
Long cleavage products corresponding to sRNAs remained immobile on the spotting origin (bottom left corners), and dinucleotides formed large
spots at the lower right corner and mid left side, while the cap structures and mononucleotide degradation products migrated further up and right.
The first dimension was run using solvent A (see materials and methods) and is displayed from bottom to the top. The second dimension was run
using solvent B (left to right). Three size fractions were investigated: ,50 nt (A–B), 50–100 nt (C–D), and 100–200 nt (E–F). The position of cold
mononucleotides Ap, Gp, Cp, Up detected by UV shadowing is indicated by purple dashed ellipses. B, D, F: chromatographies in presence of
radiolabelled standards for Gp, 7 mGp, 2,7 mGp and 2,2,7 mGp. Spots were assigned according to the reference Kieth 1995 or referred to as X.
doi:10.1371/journal.pone.0102895.g004
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2,7 mGp, and 7 mGp (Figure S11 in File S1 for chemical
structures).
Mass spectroscopic analysis of 59 end cap structure
Tandem mass spectrometry (MS/MS) was used to provide
structure confirmation for the caps that we detected in each of the
three length fractions. Each of the fractionated RNA (Figure S9 in
File S1) were first digested with RNAse T2 and nuclease P1 to
release 59-59 di-nucleotide structures, so that in conjunction with
the TLC data, we could obtain additional information about the
nature and methylation of the first transcribed nucleotide. The
sensitivity and specificity of our approach were assessed by
characterizing the cap analogs GpppG, 7mGpppG,
39O,7mGpppG (same molecular weight as 2,7mGpppG), and
2,2,7mGpppG, used to calibrate and tune the tandem MS/MS.
We then analyzed the 59-59 dinucleotide digested from THP-1
sRNA samples fractionated with PAGE electrophoresis or liquid
chromatography.
The tandem mass spectroscopy confirmed several cap structures
seen in the TLC experiments (Table 1). In particular, 2,2,7 mG
was detected in all sRNA fractions, associated with Am (all
fractions), or m6Am, Cm, Gm and Um (in sRNA .100 nt
fraction). Modified 2,7 mG and 2,2 mG cap structures were
detected along with Am in sRNAs longer than 100 nt. 7 mG was
detected with associated with mAm, Gm and Cm in sRNAs
shorter than 50 nt and sRNAs longer than 100 nt. Non-
methylated guanosine caps were detected in sRNAs shorter than
50 nt and sRNAs longer than 100 nt associated with mAm, A, and
G. We detected five dinucleotides cap structures specifically in the
sRNA fraction shorter than 50 nt: 7 mG associated with Um, A,
or G, and non-methylated guanosine associated with Cm or G. In
the fraction longer than 100 nt, potentially new cap structures with
unknown modifications were also detected (Table 1).
Cap structures that were cross-validated by the two techniques
are summarized in Table 2. In summary, we detect 2,2,7 mG in
all sRNA fractions. We also observed potential cap structures that
have not been previously reported, in particular non-methylated
guanosine cap and purine methylated guanosine caps. Like the
TLC, the MS/MS analysis also uncovered cap structures with
unknown ribonucleic acid modifications.
Discussion
There is increasingly evidence that loci for both coding and
ncRNAs produce various RNA primary transcript and short
processed versions of these. Interestingly, cap structures are
detected for both long and short RNAs. The conventional
functional roles of these cap structures are to assist the capped
RNAs in slowing the turn-over, controlling translation [2,20,21],
and assisting in sub-cellular localization [38,39]. The cap
structures found on sRNA appear to be either added onto the
original RNA during transcription (e.g. snoRNAs), or as previously
reported, have been added after processing using a novel
mechanism [14].
snRNAs were enriched the IP K121 libraries, suggesting that
our immunoprecipitation was at least partially effective. It also
enriched the libraries for short tags that aligned to TSS, suggesting
that these sRNAs are capped [14]. This result was confirmed by
Figure 5. 2,2,7 mGp is the most strongly detected methylguanosine in all length ranges. Quantitative analysis of the 2D-TLC, normalized
as a percentage of total intensity for each RNA fraction. Error bars represent the standard deviation on three replicates.
doi:10.1371/journal.pone.0102895.g005
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the sRNA CAGE libraries where 26.6% of the tags aligned to TSS
(Figure S10 in File S1), similarly to the promoter-associated
sRNAs (PASRs) reported by Kapranov et al [15]. This observation
support the idea that those transcripts have either 7 mG or
2,2,7 mG caps.
The capped sRNA libraries contained snoRNAs and tRNAs
sequences that were remarkably enriched as shorter than 50 nt in
length, indicating possible processing of these already sRNAs given
that the native transcripts are longer than 70–150 nt. We found
that 4% and 32% of the reads aligned to known tRNA and to
snoRNA loci, respectively, in these libraries. Nuclear transport of
tRNA fragments has been previously reported in several studies on
different organisms consistent of a possible functional role for these
processed RNAs [40–43]. Alternatively, these tRNA fragments
could possess 59 triphosphate originating from the incompleteness
of our enzymatic treatments. This possibility would be consistent
with the observed presence of miRNA sequences in the capped
sRNA libraries.
By pyrophosphatase cleavage and TLC, we detected a series of
59 monophosphate ribonucleotides which were reported pre-
viously as internal modified bases (1 mG, 2 mG, 2,2 mG, Cm) in
tRNAs and rRNAs [44,45]. This observation raises the the
possibility that these modified nucleotides are the result of non-
specific degradation of the analyzed sRNA. However, this
possibility is unlikely since accidental degradation to single
nucleotides is unlikely as alkaline hydrolysis requires incubation
for at least 12 h with a strong base [46] and enzymatic digestion
requires the combination of different RNases [47,48], both of
Table 1. Summary of cap structures detected in liquid chromatography-fractionated sRNA.
sRNA size ranges (nt)
Structure 20–50 50–100 .100 Calculated mass (M-) Observed mass (M-) Error (ppm)
3mGpppAm/Amppp3mG detected detected detected 827.1294 827.1308 1.69
3mGpppmAm/mAmppp3mG ND ND detected 841.1450 841.1466 1.90
2mGpppAm(1)/Amppp2mG(1) ND ND detected 813.1138 813.1157 2.34
2mGpppAm(2)/Amppp2mG(2) ND ND detected 813.1138 813.1157 2.34
mGpppmAm/mAmpppmG detected ND detected 813.1138 813.1157 2.34
3mGpppA/Appp3mG ND ND detected 813.1138 813.1157 2.34
3mGpppCm/Cmppp3mG ND ND detected 803.1184 803.1198 1.74
3mGpppGm/Gmppp3mG ND ND detected 843.1244 843.1261 2.02
3mGpppUm/Umppp3mG ND ND detected 804.1024 804.1041 2.11
mGpppGm/GmpppmG detected ND detected 815.0932 815.0951 2.33
mGpppAm/AmpppmG ND ND detected 799.0982 799.1005 2.88
mGpppCm/CmpppmG detected ND detected 775.0872 775.0885 1.68
mGpppUm/UmpppmG detected ND ND 776.0712 776.0725 1.68
mGpppG/GpppmG detected ND ND 801.078 801.079 1.25
mGpppA/ApppmG detected ND ND 785.083 785.0836 0.76
GpppCm/CmpppG detected ND ND 761.0716 761.073 1.84
GpppGm/GmpppG detected ND ND 801.078 801.0791 1.37
GpppG detected ND detected 787.062 787.0632 1.52
GpppA/ApppG detected ND detected 771.067 771.069 2.59
GpppmAm/mAmpppG detected ND detected 799.0982 799.1006 3.00
Y1pppAm/AmpppY1 ND ND detected - 841.1104 -
2mGpppY2/Y2ppp2mG ND ND detected - 825.1156 -
Y3pppAm/AmpppY3 ND ND detected - 846.1272 -
Y4pppAm/AmpppY4 ND ND detected - 774.1057 -
Y5pppAm/AmpppY5 ND ND detected - 748.127 -
Y6pppAm/AmpppY6 ND ND detected - 875.154 -
Y7pppAm/AmpppY7 ND ND detected - 875.154 -
Y8pppAm/AmpppY8 ND ND detected - 845.143 -
Y9pppAm/AmpppY9 ND ND detected - 843.1267 -
Y10pppAm/AmpppY10 ND ND detected - 843.1253 -
Y11pppAm/AmpppY11 ND ND detected - 760.0894 -
Abbreviations: ND, not detected; Nm, ribose methylated ribonucleic acid; mN, base monomethylated ribonucleic acid; 2 mN, base dimethylated ribonucleic acid; 3 mN,
base trimethylated ribonucleic acid; Yn, unknown structure 2mGpppAm(1) and 2mGpppAm(2) are isomer with different retention time on LC-MS, which may be
2,2mGpppAm and 2,7mGpppAm. Note that the order of the 59 end nucleotide is not predictable by mass spectroscopy.
doi:10.1371/journal.pone.0102895.t001
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which being very extreme conditions comparing to our procedure
for cap isolation. Importantly, these simple modified bases were
not confirmed in our mass spectroscopy experiments, suggesting
that their relative abundance is likely to be lower than the
methylguanosine caps and under the sensitivity limits for mass
spectroscopy.
To our knowledge, we report here for the first time that 2,7
dimethylguanosine in human sRNAs at reasonably abundant
amounts. In humans, 7 mG caps are hypermethylated by the
guanine-N2 methyltransferase TGS-1 (Trimethylguanosine
Synthase 1), which is inefficient in methylating other substrates,
such as non-methylated G or 2 mG [7]. The kinetic of
conversation from 7 mG to 2,2,7 mG has not as yet been
reported to occur in vivo. 7 mG and 2,2,7 mG cap structures
were double confirmed by 2D-TLC analysis and tandem mass
spectroscopy in sRNA shorter than 50 nt. 2,2,7 mG was detected
in all sRNA fractions, associated with Am (all fractions), or m6Am,
Cm, Gm and Um (,200 nt fraction). We also found typical cap
structure structures in RNAs shorter than 50 nt (7mGpppUm,
7mGpppA, 7mGpppG).
A study on human TGS-1 in vitro showed the conversion of
90% of 7mGpp substrate to 2,7mGpp after 5 min of incubation,
while the conversion of more than 50% of 2,7mGpp to
2,2,7mGpp required 15 min of treatment [49]. The efficiency of
TGS-1 on both substrates was also proven by Benarroch et al [7],
who reported similar catalytic efficiencies for the 2,7 mG and
2,2,7 mG synthase reactions. Thus, given their short half-life, it is
tempting to speculate that the 2,7 mG caps that we detected are
not intermediate products. We observed this modified cap
structure using TLC and mass spectrometry on sRNA longer
than 100 nt.
2,7 mG cap was reported previously in Sinbis virus 28S rRNA
and protozoan parasite like Giardia lamblia which has cap
guanine-N2 methyltransferase TGS-2 enzymes but not TGS-1
[50]. This is consistent with not only the possibility of the existence
of individual transcripts that carry this type of modification but
also with the possibility of the presence of uncharacterized TGS-2
enzyme in human cells or pathways that stop after the first
methylation by TGS-1.
Caps are classified as type 0, I, II, etc. according to the number
29-O-methylated nucleotides that follow the 59-59 bond. In
mRNAs, type I (or higher) caps increase the translation efficiency
[51], affect the interaction with eIF4E [52], and the transport to
the cytoplasm [38,39]. Mass spectrometry allowed us detect 29-O
methylation on the first nucleotide and therefore distinguish type 0
from the other types. In this study, surprisingly we found multiple
type 0 cap structures (mGpppC, 7mGpppG, GpppG, GpppA, and
7mGpppA) in RNA length fractions shorter than 50 nt. Thus,
these sRNAs cannot be degradation products of mRNA 59 end,
suggesting other mechanisms such as cleavage and recapping from
longer precursor RNAs. To the best of our knowledge, this is the
first report of type 0 cap structure in human RNAs.
We also found the 59-59 dinucleotides GpppmAm and
GpppmC, for which the TLC data suggests that G is the outer
59 cap nucleotide and Am or mC are the next nucleotides, because
in all length fractions Gp was the most abundant nucleotide by
TLC. Interestingly, our TLC results also showed a spot that may
be mCp, leaving open the possibility of a mCpppG cap. This result
would be unusual and in need of additional confirmation.
Our study also suggests the presence of additional uncharacter-
ized cap structures due to the absence of a reference compound in
TLC and thus making the structural information obtained from
mass spectroscopic data difficult to interpret. While performing
positive control TLC analysis to test the ability of T4 PNK to
phosphorylate nucleosides (Figure S8 in File S1) we could observe
two spots similar to what we call unknowns X1 and X4. Those
spots may reflect the possibility of the phosphorylation of both 59
and 39 position of the nucleoside. However, formal validation of
this possibility awaits further testing.
Finally, combining cDNA cloning of sRNAs, precipitation by
anti-methylguanosine antibodies, thin layer chromatography and
mass spectroscopy, we observe the unambiguous presence of caps
on sRNAs, not only in the size range corresponding to the
annotated snRNAs, but also in the size range of tRNAs (,75 nt)
and in the sRNAs shorter than 50 nt. In this size range, where we
found sRNAs aligning to the transcription start and termination
sites in known genes. We also found type 0 variants of these caps,
which may be produced by cytoplasmic capping. This analysis
approach opens the possibility of highly promiscuous 59 end
Table 2. Summary of cap structures that were cross-validated by 2D-TLC and mass spectroscopy.
59end structure Name
Known RNAs with this
modification in human
Biological function of
this RNA
sRNA fraction with this
modification (nt)
2,2,7mGp N2,N2,7-trimethylguanosine monophosphate snoRNA rRNA modification 20 nt–200 nt
2,2mGp N2,N2 dimethylguanosine monophosphate tRNA, rRNA 20 nt–200 nt
2,7mGp N2,7-dimethylguanosine monphosphate ND 20 nt–50 nt
7mGp 7-methylguanosine monophosphate tRNA, rRNA, mRNA 20 nt–50 nt 100 nt
2mGp 2-methylguanosine monophosphate tRNA 20 nt–200 nt
1mGp 1-methylguanosine monophosphate tRNA, snRNA translation 20 nt–50 nt 100 nt
Cmp 29-O-methylcytidine monophosphate tRNA, rRNA, snRNA, mRNA translation, transcription 20 nt–200 nt
Gp 59-guanosine monophosphate All 20 nt–200 nt
Cp 59-cytosine monophosphate All 20 nt–200 nt
Ap 59-adenosine monophosphate All 20 nt–200 nt
Up 59-uridine monophosphate All 20 nt–200 nt
*: Unique to this fraction.
**: First time to be reported in mammals.
doi:10.1371/journal.pone.0102895.t002
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modifications of both long and short RNAs or a novel landscape of
structural cap modifications with possible novel biological roles.
Further investigation of the biogenesis of these RNAs will be
needed to understand if they are the direct product of short-range
transcription or if they are the cleavage product of longer
templates.
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